MediWound (MDWD) EV to EBITDA (2014 - 2026)

MediWound has reported EV to EBITDA for 13 years, with the latest figure at 16.21 in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 47.53% year-over-year to 16.21 in Q2 2026; TTM through Jun 2026 was 5.43, a 43.84% increase from a year earlier, with the FY2025 full-year figure at 9.05, up 10.33% from the prior year.
• EV to EBITDA was 16.21 for Q2 2026 at MediWound, up from 27.51 in the prior quarter.
• The five-year high for EV to EBITDA was 11.04 in Q3 2023, with the low at 44.4 in Q1 2024.
• Average EV to EBITDA over 5 years is 18.72, with a median of 20.72 recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: EV to EBITDA jumped 233.99% in 2023, then plunged 4889.31% in 2024.
• Over 5 years, EV to EBITDA stood at 9.75 in 2022, then sank by 265.02% to 16.09 in 2023, then slumped by 90.35% to 30.62 in 2024, then increased by 7.17% to 28.43 in 2025, then surged by 42.97% to 16.21 in 2026.
• The last three EV to EBITDA figures came in at 16.21 (Q2 2026), 27.51 (Q1 2026), and 28.43 (Q4 2025), per Business Quant data.